Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
Abstract
Background Patients with a germline BRCA1 or BRCA2 mutation make up a small subgroup of those with metastatic pancreatic cancer. The poly(adenosine diphosphate–ribose) polymerase (PARP)...
Paper Details
Title
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
Published Date
Jun 2, 2019
Volume
381
Issue
4
Pages
317 - 327
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History